Munich - Delayed Quote • EUR
Iovance Biotherapeutics Inc (2LB.MU)
At close: April 26 at 8:03 AM GMT+2
Loading Chart for 2LB.MU
DELL
- Previous Close
10.99 - Open
11.26 - Bid 10.82 x --
- Ask 10.91 x --
- Day's Range
11.26 - 11.26 - 52 Week Range
3.16 - 16.82 - Volume
63 - Avg. Volume
97 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 7, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 2LB.MU
Performance Overview: 2LB.MU
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
2LB.MU
39.30%
S&P 500
6.92%
1-Year Return
2LB.MU
110.77%
S&P 500
25.26%
3-Year Return
2LB.MU
57.71%
S&P 500
22.00%
5-Year Return
2LB.MU
11.92%
S&P 500
74.29%
Compare To: 2LB.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2LB.MU
Valuation Measures
As of 4/26/2024
Market Cap
3.03B
Enterprise Value
2.84B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.32k
Price/Book (mrq)
5.60
Enterprise Value/Revenue
2.39k
Enterprise Value/EBITDA
-6.65
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Company Insights: 2LB.MU
2LB.MU does not have Company Insights